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A DNA bank has been created from the Millennium Cohort Study (MCS) saliva samples. 
A total of 23,336 samples are available, from 9,259 cohort members (4,630 males and 4,629 
females), 8,898 mothers and 5,179 fathers. There are 4,533 mother, child, father ‘triads’. This 
paper describes the collection of the saliva samples from cohort members and their biological 
parents in the MCS. It analyses response rates and predictors of response, and details the DNA 
extraction, genotyping and imputation procedures performed on the data.
Key words genetic data • Millennium Cohort Study • longitudinal • ethnic diversity • 
nationally representative population
Key messages
•  It describes the collection of saliva samples in the Millennium Cohort Study, from cohort 
members and their resident biological parents.
•  It analyses response rates and predictors of response.
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•  It details the DNA extraction, genotyping and imputation procedures performed on the 
data.
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Introduction
The Millennium Cohort Study (MCS) is a large and nationally representative birth 
cohort study following the lives of children born across the UK around the turn of 
the millennium (Connelly and Platt, 2014; Joshi and Fitzsimons, 2016). Data collected 
through the study include a range of detailed social, behavioural and economic 
measures; cognitive, educational, emotional and physical development; aspirations, 
identity, well-being and personality. There have been seven waves to date, at ages 9 
months, 3, 5, 7, 11, 14 and 17 years. A key feature of the sixth (age 14) wave of the 
study was the collection of genetic information, via saliva, from cohort members 
(that is, those who are part of the cohort born at the turn of the millennium) and 
their resident biological parents, that is, parents who were living with them at the 
time of interview. This paper provides information on the data collection process, 
response rates, DNA extraction, genotyping, quality control and imputation and 
genetic ancestry of this cohort.
The addition of genetic information to this rich, longitudinal data resource will 
enable discovery of genome-wide association study (GWAS) analyses based on 
study focus traits, trajectories and familial phenotypes. We expect this resource to 
trigger a range of studies into how genetic and environmental factors shape human 
development across the life course. This includes both the use of novel genetic 
predictors of early life factors and analyses using genetics as a lever for causality 
(Mendelian randomisation, MR). Genetic data will, in conjunction with the high-
quality phenotype data (Connelly and Platt, 2014; Joshi and Fitzsimons, 2016), also 
enable studies of the longitudinal or fine-scale phenotypic associations of already-
discovered genetic associations from larger cohorts. Its diverse population, including 
continental and complex ancestries, increases representation of certain groups and 
increases opportunities to understand how genotype influences phenotype. The MCS 
is unique in being the only population-based, nationally representative study in the 
UK containing genetic triads.
The paper proceeds as follows: background; an overview of the fieldwork collection; 
a discussion of the DNA extraction process; response rates; genotyping, quality 
control and imputation; illustration of the resource’s self-described ethnic diversity 
and continental genetic ancestry; and accessing the data.
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Background
The sixth, or age 14, wave of the MCS took place across the UK from January 2015 
to March 2016. Interviews were conducted with 11,726 families, of which there were 
11,872 cohort members (Fitzsimons, 2017), representing a response rate of 76.3% (of 
the eligible sample at age 14). This was a particularly extensive and innovative wave, 
containing several elements including interviews and self-completion questionnaires 
with main parent (mostly the mother) and the main parent’s resident partner (where 
applicable), self-completion with cohort members, physical measurements, cognitive 
assessments, saliva samples, accelerometer collection and time diaries for cohort 
members to record how they were spending their time. The study obtained ethical 
approval from London-Central REC (13/LO/1786).
A key feature of the sixth wave was the collection of saliva samples from cohort 
members and their biological parents as part of the home visit carried out by 
interviewers. Integrating the collection of saliva samples from children and their 
biological parents into home visits carried out by trained interviewers brought with 
it several advantages. Associated cost and logistical considerations were particularly 
important in implementing it at scale across the UK, and in a study involving young 
people (Sun and Reichenberger, 2014). While lay interviewers are increasingly 
involved in the collection of biomedical measures using non-invasive methods (McFall 
et al, 2014), our study represented a significant departure from previous longitudinal 
studies that are tagged on to a clinic visit (for example, the Avon Longitudinal 
Study of Parents and Children, UK Biobank), or taken by nurse interviewers as part 
of a home visit (for example, the Health Survey for England, the 1958 National 
Child Development Study, the 1970 British Cohort Study, and the UK Household 
Longitudinal Study (UKHLS)). Follow-up nurse or clinic visits tend to suffer from 
high dropout rates and are also relatively expensive (Clemens et al, 2012). Where 
clinics or nurse visits are not otherwise required, other techniques have been used. For 
instance, the 1958 National Child Development Study in the UK, and the Wisconsin 
Longitudinal Study in the US, have included self-administered saliva sample collection 
posted back by respondents. Our approach had been piloted on a small scale a few 
years previously (Calderwood et al, 2014). Most comparable to our approach is the 
US Fragile Families and Wellbeing Study, which collected saliva samples in the homes 
at age 9, from cohort members and mothers, achieving compliance rates of 85% and 
78% respectively (Fragile Families, 2019).
Saliva is widely regarded as the preferred minimally invasive approach to collecting 
samples to enable genotyping. Compared to the alternative methods for DNA 
collection, such as blood samples, its advantages include an ability to be collected by 
interviewers, rather than the clinically trained such as by a phlebotomist or nurse. 
When collected in an appropriate manner, preservative samples can be stored at 
ambient temperatures for up to 30 months, which both alleviates time pressures in 
terms of delivery to the laboratory and concerns about degradation which can be 
an issue following freeze/thaw cycles of blood. DNA purification is straightforward 
and the resulting material, compatible with major genotyping technologies, provide 
reliable results.
One drawback is that saliva samples collected and processed using methods described 
in this paper, using Oragene kits, are largely limited to (epi-)genomic assays, unlike 
biosamples such as blood which can provide other measures, such as metabolomics, 
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clinical chemistry measures and proteomics. Another potential disadvantage of saliva 
collection include lower mean endogenous or host DNA yields because of inclusion 
of exogenous source material such as oral microbial DNA (Abraham et al, 2012; 
Gudiseva et al, 2016; Bruinsma et al, 2018). However previous studies have found that 
saliva samples provide sufficient DNA for genotyping (Gudiseva et al, 2016). Indeed 
(Bruinsma et al, 2018) show that it is possible to obtain a higher quantity of DNA 
from saliva than whole blood samples of the same volume, consistent with findings 
reported by (Hansen et al, 2007). Saliva has also been found to provide higher quality 
DNA than other non-invasive methods, such as buccal swabs (Rogers et al, 2007).
Collection of saliva samples in the Millennium Cohort Study
Collection protocols
Prior to the age-14 fieldwork, interviewers attended a three-day training session 
covering all aspects of the upcoming survey including consent protocols and saliva 
collection. In addition, alongside the in-person training, interviewers were provided 
with detailed written instructions on the collection of the samples in the home (see 
Appendix); packaging and return of samples to the laboratory; strict protocols were 
provided in order to reduce contamination from foreign DNA by bacteria, fungi 
and food remnants. Interviewers were required to carry out two practice sessions 
of saliva sample collection, before obtaining accreditation at the end of the training 
(Ipsos MORI, 2017).
The Oragene® 500 DNA Self-Collection Kit made by DNA Genotek was used 
to collect saliva samples.1 The Self-Collection Kit is a repository for the collection, 
preservation, transportation and purification of DNA from saliva. Benefits of the kit 
include the fact that they assure no sample degradation, even when stored at room 
temperature for up to 30 months, and the manufacturer-stated median DNA yield 
from the kit is 110 μg from a 2 ml saliva sample (Birnboim, 2004).
All cohort members were eligible to provide a saliva sample, along with their 
biological mother and father if resident in the household and available.
The consent process was as follows. Written consent was required from parents 
for their own samples, and for their child to provide a sample, and the 14-year-old 
cohort members themselves had to provide verbal consent. Interviewers collected 
written consent using carbon-copy consent forms, with parents retaining a copy of 
the consent they had provided. Once consent forms were received in the office from 
interviewers, each form was checked to ensure valid consent had been provided. This 
entailed ensuring the parent had ticked or initialled the appropriate boxes as directed, 
and had signed the form. In cases where ticks/initials or a signature were missing, 
consent was deemed invalid and the corresponding saliva sample was destroyed. 
Consent could be withdrawn at any time, in writing, without providing a reason.
Transfer protocols
Samples were collected by interviewers from the cohort member and the biological 
mother and father and were packaged in accordance with the transportation of 
biological substances regulations, and were sent to the laboratory at the University 
of Bristol by first-class post. Samples could be sent from a post office or using post 
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boxes. Samples arrived daily at the Bristol Bioresource Laboratory. Further details 




Saliva samples for DNA extraction were received in Bristol between January 2015 
and May 2016. Samples were logged on arrival and stored at room temperature. Lists 
of samples logged were sent weekly to Ipsos MORI, the agency conducting the 
fieldwork. This was in order for Ipsos MORI to confirm that the appropriate signed 
consent had been obtained to collect saliva samples. Lists of those with confirmed 
consent were returned from Ipsos MORI to the lab weekly. Final lists of samples with 
confirmed consent and those for disposal were received in October 2016.
DNA extraction and quantification
DNA was extracted from samples using an automated extraction robot (Tecan 
Freedom EVO-HSM Workstation using ReliaPrep™ Large Volume HT gDNA 
Isolation System).
Total DNA was quantified by fluorometic assay, using picogreen (Quant-
iTTMPicogreenTMdsDNA reagent (ThermoFisher Scientific)). Assays were 
performed using a Tecan Freedom Evo liquid handling robot and read on an Infinite 
F2000 Proreader.
Approximately 90% of samples provided yields of at least 20 µg, sufficient DNA 
for a range of genetic studies. As expected, for saliva samples, there were large 
variations in DNA yield. The yield from the child samples was, at 88%, lower than 
adults (91%), as has been seen in a number of studies (for example, Gassó et al, 2014; 
Nishita et al, 2009).
All samples were extracted well within the recommended storage time of five years 
for the Oragene kits, with the mean storage time of 304 days, minimum 87 days and 
maximum 654 days.2
Response
In this section we show response rates for different study participants (cohort members, 
mothers, fathers), and document the main factors associated with response.
Figure 1 presents the numbers of eligible participants providing a saliva sample, 
separately by cohort member, mother and father. It also shows how many produced 
a ‘usable’ sample, that is, one providing a DNA extraction yield greater than zero. 
Looking first at the cohort members (the 14-year-olds), of those eligible, 81.4% 
provided a saliva sample, and DNA was extracted for 78.4% of eligible cohort 
members. Similar rates are observed for mothers, where 82% of those eligible provided 
a saliva sample, resulting in usable samples for 79.1% of eligible main respondents. 
Looking at fathers, we see that response rates were around 10 percentage points lower 
than mothers, at 71.5% of eligible (n = 7,544 biological fathers in the household), 
with 68.7% of usable samples received. A DNA bank has been created from the MCS 
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saliva samples. A total of 23,336 samples are available, from 9,259 cohort members, 
8,898 mothers and 5,179 fathers. There are 4,533 mother, child, father ‘triads’.
The vast majority of usable saliva samples are from singletons, with samples from 
90 twin pairs, and six sets of triplets, as shown in Table 1.
Table 2 shows the distribution of sample volumes, separately for cohort members, 
mothers and fathers. As the table shows, most samples were of the correct volume. 
If taken correctly, the final volume should be 4 ml: as can be seen from the table, 
just under 73% of samples had an estimated volume greater than 4 ml, with mothers 
providing the highest quality samples; 7% of samples had an estimated volume of less 
than 3 ml, suggesting that either no sample was given and the tube only contained 
preservative, or that the preservative solution was not added and only saliva was 
present. There were discoloured samples ranging from pale yellow to very dark 
brown and approximately 49% had some food contamination and 17% had marked 
food contamination (based on visual inspection). However this had no impact on the 
quality of DNA extracted. A complete analysis of quality of the data is presented in 
the next section, ‘Genotyping’.
Figure 1: CONSORT 2010 Flow Diagram3
Assessed for eligibility for wave 6 (n=15,415) 
Excluded (n=478) 
♦ Died (n=1)
♦ Emigrated (n=4 5)
♦ Untraced movers (n=345)
♦ Traced movers/ran out of time (n=87)




♦ Broken appointment (n=409)
♦ Other (n=155)
Productive sample of families at w6 (n=11,726)
Cohort member assessed for saliva
sample eligibility(n=11,884)
Household assessed for biological
mother saliva sample eligibility (n=
11,726) 
Household assessed for biological
father saliva sample eligibility (n=
11,726)
Excluded (n=2,273)
Ineligible care home (n=8)








Ineligible: Not biological father 
(majority)/ other (n=4,182)
Unproductive (n=2,152)
Saliva sample collected (n=9,611)
Invalid consent (n=251)
Saliva sample successful, i.e. with 
DNA extracted (n=9,259) 
Saliva sample collected (n=5392)
Invalid consent (n=191)
Saliva sample successful, i.e. with 
DNA extracted (n=8,898)
Saliva sample successful, i.e. with 
DNA extracted (n=5,179)
Saliva sample collected (n=9,221)
Invalid consent (n=291)
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In Table 3, we show combinations of responses within the household. Triads of DNA 
samples are available for 4,533 households, and mother–child pairs are available for 
a further 3,913 households – together representing almost 90% of households who 
gave any saliva sample.
Finally, we analyse factors associated with response including: age in months and 
ethnicity of participants, sex of cohort member, household highest educational 
qualification, and country. We run four separate linear probability models, predicting 
response for: cohort members, mothers, fathers and triads. Estimates are shown in 
Table 4. Across the board, we see differences in response by education level (those 
with higher levels more likely to provide a sample) and ethnicity (ethnic minorities 
less likely to have provided a sample, particularly those from Black African or Black 
Caribbean backgrounds). There are no differences by education level in the provision 
of triads, but ethnic differences remain.






Note: Among twins, in seven cases a saliva sample was provided by one twin only. These are included in the 
singleton count.
Table 2:  Sample volume
Cohort member Mother Father Total
Volume:         
Less than 3 ml 700 7.56% 433 4.87% 520 10.04% 1,653 7.08%
3–3.9 ml 1,970 21.28% 1,583 17.79% 1,123 21.68% 4,676 20.04%
4–4.9 ml 5,910 63.83% 6,010 67.54% 3,186 61.52% 15,106 64.73%
5 ml or more 679 7.33% 872 9.80% 350 6.76% 1,901 8.15%
 9,259  8,898  5,179  23,336  
Table 3:  Composition of samples
N %
Triad (M, F, CM) 4,533 46.77
M, CM, no F 3,913 40.38
F, CM, no M 378 3.90
M, F, no CM 186 1.92
M only 266 2.74
F only 82 0.85
CM only 333 3.44
Total 9,691 100
Notes: Figures are at the household level; households with multiple cohort members are included once.



























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A total of 21,432 DNA samples from 21,418 individuals were run on a total of 
21,631 arrays (902 chips) (some DNA samples were repeated when quality checks 
failed), as shown in the first row of Box 1. Infinium global screening arrays-24 v1.0 
from Illumina, with 24 samples on each chip, were used following manufacturer’s 
instructions. In brief, 200 ng of DNA was hybridised to each array following the 
manufacturer’s standard protocol. Samples (10,578) with a concentration below 
40 ng/ul were concentrated before use by lypholisation followed by resuspension 
in appropriate volume of sterile water. Samples with insufficient DNA (n = 1,918) 
were excluded from genotyping.
Arrays were read on an Illumina iScan System (scanner ID N350), using FGPA 
version 4.0.20 and iScan Control Software version 3.4.8. Hybridisation/fluorescence 
signals were written to idat files. Data for a total of 21,556 arrays derived from 21,368 
individuals passed iScan quality control and were passed for genotype calling, as shown 
in the second row of Box 1.
Genotype calling
Genotype calling for all 21,556 arrays was performed using the Genome Studio 
v2.0.4 graphical user interface, on a single computer running Windows 7, in a 
single batch. Data for 618,540 variants was written to a final manifest file and plink 
ped format using the plink export module, and subsequently converted to a binary 
ped or bed file using plink2 (Purcell et al, 2007). Genotype calls were then quality 
controlled (QC), for samples and single nucleotide polymorphism (SNPs) using 
summary estimates generated by QCtools_v2.0.1,4 plink, and bespoke R  scripts, 
as follows. First, individuals were jointly identified and subsequently excluded for 
having a missingness proportion greater than 20% (n = 199), and/or an estimated 
heterozygosity greater than or less than five standard deviations from the population 
mean heterozygosity estimate (n = 120). As there was overlap between these groups, 
this led to 207 individuals in total being excluded. Second, 51 SNPs were excluded 
for missingness greater than 20%, followed by the exclusion of 1,473 SNPs for 
genomic mapping duplicity, totalling 1,524 SNP exclusions. Third we estimated a set 
of unrelated individuals using plink2’s greedy, Ajk relatedness estimator using default 
parameters of the function rel-cutoff. This identified 11,176 individuals unrelated at 
roughly the fifth degree (0.025). No exclusions were made with this data, but this list 
Box 1:  Genotyping statistics
Genotyping performed Arrays Biological samples Individuals
Placed on an array 21,631 21,432 21,418
Array data available 21,556 21,373 21,368
Passed genotype quality control 21,349 21,197 21,192
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of unrelated individuals is used later. Fourth, we merged the MCS cohort data set with 
the 1000 Genomes phase three data, which is derived from 26 global populations, 
providing us with a data set of 278,052 shared and strand matched SNPs. With this 
temporary, combined data set we estimated principal components using only the 
data from the 1000 Genomes data and subsequently projected the MCS data onto it. 
Using the eigenvectors of principal components (PC) one and two we identified the 
two-dimensional boundary in which the 1000 Genomes GBR (British in England 
and Scotland) population occupied and then extracted the sample identifiers for all 
9,095 unrelated MCS individuals, as identified in step three, that fell within that 
space. We note that including relatives, 14,657 MCS individuals did fall within this 
GBR population space, and that no MCS individuals were identified as extreme 
outliers on the first five PC as defined using the 1000 Genomes phase 3 data set. 
Fifth, using these 9,095, putatively unrelated individuals with strong 1000 Genomes 
GBR population PC1 and PC2 mapping association, we estimated the Hardy-
Weinberg (HW) statistic. Steps three and four of this QC protocol were carried out 
to comply, as best we can, with the randomly mating, non-structured population 
assumption of the HW principle. The other assumptions of the HW principle that 
may influence this data – no overlapping generations, no mutation, no selection, 
equal distribution of alleles among the sexes – are being ignored. Using a p-value 
of 2.5 × 10−8, 16,371 SNPs were excluded for exhibiting strong deviations from 
HW equilibrium. No exclusions have been made regarding mismatches between 
the self-reported and genotype predicted sex. A total of 602,181 SNPs and 21,349 
arrays, derived from 21,192 individuals passed these QC measures. A breakdown of 
how many arrays, samples and individuals that went through genotyping is shown in 
Box 1. In addition, the number of males, females, parents and children in the cohort 
with genotype data is provided in Box 2.
Imputation
To prepare for imputation, we followed the instructions on the Michigan Imputation 
Server (MIS) website5 (Das et al, 2016), and using our QC data set we converted the 
data to VCF format, split by chromosome and sorted by chromosome and position, 
using plink2.0 and tabix function of VCFtools (Danecek et al, 2011). We subsequently 
validated the mapping and strand allocation of our variants using prepared scripts6 
from Will Rayner and the McCarthy group,7 as instructed by MIS. Prepared data 
was submitted to the MIS, phased with Eagle.v2.4 (Loh et al, 2016) and imputed to 
Haplotype Reference Consortium release 1.18 (HRC r1.1; Haplotype Reference 
Box 2: Genotype data availability
Genotype data available Parent Child Step-parent Sex totals
Female 8,212 4,072 0 12,284
Male 4,803 4,101 4 8,908
Relationship totals 13,015 8,173 4 21,192
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12
Consortium, 2016) using Minimac.v4 (Howie et al, 2012; Fuchsberger et al, 2015). 
Imputation chunk chr14:1-20Gb, corresponding to the short arm of chromosome 
14, a gene desert, failed to impute given the paucity of genotyped data in this region.
Individual ancestry
Genetic ancestry at the continental level was estimated for each MCS individual using 
the MCS data projected on the 1000 Genomes data set as described in the earlier 
subsection called ‘Genotype Calling’. These analyses use principal components that 
reduce the genotype data into orthogonal eigenvectors (principal components or 
PCs) describing how the data covaries. The first PC explains the largest proportion of 
variation present in the data, and each subsequent one explains a smaller and smaller 
proportion of the total variation. PC 1–4 and a k (number of clusters) from 2 to 20 
were used to identify clusters and estimate the proportion of total variation explained 
among clusters. At a k of five the proportion of variation explained by clusters 
plateaus, explaining 92.9% of the total variation (Figure 2A). The five k clusters are 
largely consistent with the five super-populations identified by the 1000 Genomes 
project Africa (AFR), America (AMR), East Asia (EAS), Europe (EUR) and South 
Asia (SAS) providing a criteria to assign MCS individuals to a continental ancestry 
(Figure 2B).9 We note that these continental assignments are limited by both the data 
used (SNPs and 1000 Genomes populations), the assumption of a single ancestry 
Figure 2: K-means clustering variance explained by clusters
Legend: K-means clustering results. (A) Proportion of total variance explained by groups. X-axis defines the 
number of k clusters; y-axis defines the proportion of total variance in principal components 1–4 explained 
between clusters. (B) A table of the K5 clusters and the grouping of individuals from the 1000 Genomes 
individual pre-defined super-populations (Africa (AFR), America (AMR), East Asia (EAS), Europe (EUR), South 
Asia (SAS)) and the Millennium Cohort study samples (MCS).
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and the methodology, and are solely intended to provide an overview of the global 
genetic diversity of this cohort. Given the data 86.75% of individuals are of European 
ancestry, 10.46% are of South Asian ancestry, 2.37% are of African ancestry, 0.34% is 
of East Asian ancestry, and 0.07% is of American ancestry (Figure 2B).
The self-described ethnic group of 7,822 children aged 13 to 15 was compared to 
assigned continental clusters to compare and contrast individual cultural ethnicity with 
continental genetic ancestry. During the completion of questionnaires individuals were 
free to describe the ethnic group they belonged to as, among others, Bangladeshi, 
Black African, Black Caribbean, Indian, mixed, other, Pakistani, white, unknown or 
free to refuse to answer the question. We would anticipate a non-random overlap of 
these two categorical traits, but one does not necessitate or dictate the other. We do 
observe a non-random association between these two variables (hypergeometric test, 
Monte Carlo simulated p-value = 3.9×10−6), but there are notable disagreements 
(Figure 3). For example, 26.9% of Black Caribbeans and 16.0% of Black Africans 
are assigned to the EUR genotypic cluster. These observations do not negate an 
individual’s self-described ethnicity, nor do these limited analyses quantify continental 
genetic ancestry. However, it does exemplify the ethnic and genetic diversity of this 
data set and highlights the needed careful consideration of both parameters when 
building analytical models of these data.
Accessing the data
The genetic data are available for access for research, both on their own and alongside 
the rich phenotype data collected in the MCS. Application is via the Data Access 
Committee of the Centre for Longitudinal Studies, details at: https://cls.ucl.ac.uk/
data-access-training/genetic-data-and-biological-samples/
Figure 3: K-means clustering variance explained by clusters
Legend: MCS young people principal components 1 and 2. Shapes define individual self-described ethnicity; 
the five colours define k-means continental ancestry. The eight self-described ethnicities are further plotted 
individually to aid visualisation.




 2  http://www.dnagenotek.com/US/pdf/PD-PR-012.pdf.
 3  For details of issued and achieved samples at previous MCS waves, see Table 1 of Connelly 
and Platt (2014).
 4  https://www.well.ox.ac.uk/~gav/qctool/.
 5  https://imputationserver.sph.umich.edu.
 6  https://www.well.ox.ac.uk/~wrayner/tools/HRC-1000G-check-bim-v4.2.11.zip.
 7  https://www.well.ox.ac.uk/~wrayner/tools/.
 8  http://www.haplotype-reference-consortium.org.
 9  https://www.internationalgenome.org.
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Appendix: Fieldwork Interviewer Instructions
Saliva collection instructions
Advance instructions for parents
How do you give a saliva sample?
You and your child will be asked to spit your saliva into a small container. It is very 
easy and can be done in private. About half a teaspoon of saliva is needed. This 
typically takes about 5 minutes. There is no risk of harm to you or others when 
giving a saliva sample. You should not eat, drink, smoke or chew gum for 30 minutes 
before giving a saliva sample.
Advance instructions for young people
How?
Giving a saliva sample is very easy – the interviewer will explain how. You will be 
given a small container and asked to spit into it. You can do it in private. You should 
not eat, drink, smoke or chew gum for 30 minutes before giving a saliva sample. 
There is no risk of harm to you or others when giving a saliva sample. Your parent(s) 
will be asked to do the same thing.
Instructions for interviewers in the household
4.4.1. Preparing for the saliva sample collection
Please ensure that the person giving the sample has not eaten, drunk, smoked, or 
chewed gum in the 30 minutes prior to providing the sample. Contaminated samples 
may not be usable.
The front page of the consent booklet has peel-off barcode labels for the main 
respondent, partner and the young person saliva tubes. You must stick the relevant 
label on the saliva collection tube immediately before sample collection. The barcode 
must be stuck along the length of the tube to enable it to be scanned at the lab; it 
must NOT be wrapped around the tube. Please ensure that you do not cover the 
fill line with the label.
4.4.2. Collecting the saliva sample
This is a diagram of the Oragene collection tube.
funnel lid
small cap for tube
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 1.  Ask the respondent to spit into the container until the amount of 
liquid saliva (not bubbles) has reached the fill line marked on the 
side of the tube. This usually takes about 5 minutes.
 2.  Please encourage them to try to complete the collection within 30 
minutes. If they are having difficulties producing enough saliva, 
it sometimes helps if people close their mouths and wiggle their 
tongues or rub their cheeks (or think of their favourite food!)
 3. Please put on your disposable gloves.
 4.  When the amount of liquid saliva has reached the fill line on the 
side of the tube, ask the respondent to pass the tube to you.
 5.  Hold the tube upright with one hand. If there are a lot of bubbles in 
the tube, tap the tube gently against a hard surface. Close the lid 
with the other hand by firmly pushing the lid until you hear a loud 
click. The liquid in the lid will be released into the tube to mix with 
the saliva. MAKE SURE THE LID IS CLOSED TIGHTLY.
 6. Hold the tube upright. Unscrew the tube from the funnel.
 7.  Pick up the small cap for the tube. Use the small cap to close the 
tube tightly.
 8. Shake the capped tube for 5 seconds to mix.
 9.  Put the tube into the small plastic bag with the absorbent material 
and seal tightly.
10.  Place the funnel, Oragene packaging and gloves in the disposable 
bag for waste. Ask the respondent to dispose of it in the household 
rubbish.
11. Use the hand gel to clean your hands.
4.4.3. Packaging the saliva sample
You need to write the barcode number from the consent form onto the despatch 
form (please also make sure that you have entered your interviewer number in the 
space provided).
Place the sample and the despatch form in one of the white jiffy bags.
The maximum number of saliva samples you should post in one jiffy bag is 15.
4.4.4. Recording saliva collection information on the consent booklet
You will also be required to record the date each sample was collected on the front of 
the consent booklet. You will also be required to confirm that the respondent hasn’t 
eaten, drunk, smoked or chewed gum within the 30 minutes prior to collection.
4.4.5. Recording the saliva barcode number in CAPI
You must input the saliva barcode numbers into CAPI in the Final Element module, 
which you will complete at home. You will need to use the consent form to do this. 
This is the only way we will know which saliva sample belongs to which respondent. 
You will also be asked to record any reasons for refusal, any problems with the saliva 
sample collection and the information you recorded on the front of the consent 
booklet in the Final Element module.
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4.4.6. Storing and despatching the samples
The samples should be stored at room temperature so please do not store them in 
the fridge. Once a week during fieldwork, please gather all of the samples that you 
have collected together, check that you have entered the saliva barcode number for 
each sample on the despatch note(s), and post them back to the Bristol address. You 
can post them back using a normal post box. You can post samples to Bristol even 
if you have not completed the Final Element module in CAPI (for example, if you 
expect to return to the household to complete outstanding survey elements).
